Virtus ETF Advisers LLC Cara Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $16,249 - $40,773	-3,323 Reduced 27.73%	8,659 $42,000
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $12,547 - $18,044	-1,413 Reduced 10.55%	11,982 $128,000
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $824 - $1,256	100 Added 0.75%	13,395 $125,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $13.84 $2,734 - $5,079	367 Added 2.84%	13,295 $121,000
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $7,663 - $9,753	-771 Reduced 5.63%	12,928 $157,000
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $13,177 - $19,935	-1,099 Reduced 7.43%	13,699 $167,000
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $8,997 - $12,510	-779 Reduced 5.0%	14,798 $229,000
Q2 2021 Aug 10, 2021	SELL	$12.38 - $29.19 $56,551 - $133,339	-4,568 Reduced 22.68%	15,577 $222,000
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $5,214 - $7,511	346 Added 1.75%	20,145 $437,000
Q4 2020 Feb 12, 2021	SELL	$12.72 - $16.16 $8,636 - $10,972	-679 Reduced 3.32%	19,799 $300,000
Q3 2020 Nov 13, 2020	SELL	$12.34 - $17.92 $34,589 - $50,229	-2,803 Reduced 12.04%	20,478 $261,000
Q2 2020 Aug 05, 2020	BUY	$12.39 - $17.33 $19,539 - $27,329	1,577 Added 7.27%	23,281 $398,000
Q1 2020 May 14, 2020	SELL	$9.12 - $17.78 $28,873 - $56,291	-3,166 Reduced 12.73%	21,704 $287,000
Q4 2019 Feb 13, 2020	BUY	$16.11 - $25.98 $190,484 - $307,187	11,824 Added 90.63%	24,870 $401,000
Q3 2019 Nov 12, 2019	SELL	$18.28 - $26.91 $13,289 - $19,563	-727 Reduced 5.28%	13,046 $238,000
Q2 2019 Aug 13, 2019	BUY	$17.68 - $21.57 $243,506 - $297,083	13,773 New	13,773 $296,000
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $307,984 - $419,765	-21,373 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$12.45 - $23.47 $85,407 - $161,004	-6,860 Reduced 24.3%	21,373 $278,000
Q3 2018 Nov 14, 2018	SELL	$17.57 - $23.95 $354,738 - $483,550	-20,190 Reduced 41.7%	28,233 $676,000
Q2 2018 Aug 10, 2018	SELL	$11.6 - $19.27 $127,054 - $211,064	-10,953 Reduced 18.45%	48,423 $927,000
Q1 2018 May 14, 2018	BUY	$11.77 - $16.08 $373,591 - $510,395	31,741 Added 114.86%	59,376 $735,000
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $103,419 - $122,777	8,720 Added 46.1%	27,635 $338,000
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $21,798 - $28,268	1,730 Added 10.07%	18,915 $259,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,185	17,185 $264,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$11 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$8.31 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.59 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.43 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.41 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account